Close Menu

The president and CEO of the Biotechnology Industry Organization, James Greenwood, tells the Boston Globe that the biotech companies will, for the most part, survive the recession. As a whole, he says, the industry has just started to make money, though because of the economy, there is a risk of some companies losing out. Greenwood also discusses generic biologics and data exclusivity as well as healthcare reform.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

European regulators have begun a rolling review of Russia's Sputnik V SARS-CoV-2 vaccine, Reuters reports.

Science reports that Science Foundation Ireland is seeking annual budget increases.

According to the Financial Times, a UK university group is pushing Elsevier to lower its journal fees.

In Nature this week: satellite tracking and genome sequencing combination used to examine migration patterns of peregrine falcons, and more.